Page last updated: 2024-10-30

loperamide and Bowel Diseases, Inflammatory

loperamide has been researched along with Bowel Diseases, Inflammatory in 6 studies

Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.

Research Excerpts

ExcerptRelevanceReference
"Loperamide has a relaxing effect on localized and segmental large-bowel spasms."2.68A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome. ( Bernklev, T; Efskind, PS; Vatn, MH, 1996)
"When treating diarrhea, physicians need to control inflammatory activity using appropriate treatment algorithms."2.44Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions. ( Hanauer, SB; Shah, SB, 2007)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Selby, A1
Reichenbach, ZW1
Piech, G1
Friedenberg, FK1
Twardowska, A1
Fichna, J1
Binienda, A1
Major, GAD1
Gunn, D1
Hanauer, SB2
Shah, SB1
Efskind, PS1
Bernklev, T1
Vatn, MH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Double Blind, Placebo Controlled, Cross Over Study to Investigate the Effectiveness and Safety of Eluxadoline in the Treatment of Diabetic Diarrhea[NCT04313088]Phase 2/Phase 30 participants (Actual)Interventional2022-07-01Withdrawn (stopped due to This study did not enroll any subjects)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for loperamide and Bowel Diseases, Inflammatory

ArticleYear
Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea.
    Digestive diseases and sciences, 2019, Volume: 64, Issue:12

    Topics: Antidiarrheals; Autonomic Nervous System Diseases; Blind Loop Syndrome; Celiac Disease; Diabetes Mel

2019
Enkephalinases as a new pharmacological target in the treatment of gastrointestinal tract disorders
    Postepy biochemii, 2020, 09-30, Volume: 66, Issue:3

    Topics: Antidiarrheals; Diarrhea; Gastrointestinal Diseases; Humans; Inflammatory Bowel Diseases; Irritable

2020
Chronic diarrhoea in adults: what not to miss.
    Current opinion in gastroenterology, 2019, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Adenoma; Antidiarrheals; Bile Acids and Salts; Celiac Disease; Chronic Disease; Colo

2019
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.
    Reviews in gastroenterological disorders, 2007, Volume: 7 Suppl 3

    Topics: Animals; Antidiarrheals; Colitis, Ulcerative; Crohn Disease; Diarrhea; Gastrointestinal Transit; Hum

2007

Trials

1 trial available for loperamide and Bowel Diseases, Inflammatory

ArticleYear
A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome.
    Scandinavian journal of gastroenterology, 1996, Volume: 31, Issue:5

    Topics: Adult; Antidiarrheals; Double-Blind Method; Female; Humans; Inflammatory Bowel Diseases; Loperamide;

1996

Other Studies

1 other study available for loperamide and Bowel Diseases, Inflammatory

ArticleYear
The benefits of loperamide in the treatment of patients with IBS or IBD. Introduction.
    Reviews in gastroenterological disorders, 2007, Volume: 7 Suppl 3

    Topics: Antidiarrheals; Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Loperamide

2007